Related references
Note: Only part of the references are listed.18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease
Ryuichi Harada et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Structure-Activity Relationship of 2-Arylquinolines as PET Imaging Tracers for Tau Pathology in Alzheimer Disease
Tetsuro Tago et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Tracer Kinetic Analysis of (S)-18F-THK5117 as a PET Tracer for Assessing Tau Pathology
My Jonasson et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
[18F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease
Ryuichi Harada et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
PET Quantification of Tau Pathology in Human Brain with 11C-PBB3
Yasuyuki Kimura et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Tau imaging: early progress and future directions
Victor L. Villemagne et al.
LANCET NEUROLOGY (2015)
Tau PET Imaging in Alzheimer's Disease
Nobuyuki Okamura et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2014)
Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F18]-T808
David T. Chien et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Quantitative Analysis of Amyloid Deposition in Alzheimer Disease Using PET and the Radiotracer 11C-AZD2184
Hiroshi Ito et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Radiosynthesis, Photoisomerization, Biodistribution, and Metabolite Analysis of 11C-PBB3 as a Clinically Useful PET Probe for Imaging of Tau Pathology
Hiroki Hashimoto et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
[18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease
Chun-Fang Xia et al.
ALZHEIMERS & DEMENTIA (2013)
Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807
David T. Chien et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Novel 18F-Labeled Arylquinoline Derivatives for Noninvasive Imaging of Tau Pathology in Alzheimer Disease
Nobuyuki Okamura et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Alzheimer disease therapy-moving from amyloid-β to tau
Ezio Giacobini et al.
NATURE REVIEWS NEUROLOGY (2013)
Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls
Masahiro Maruyama et al.
NEURON (2013)
The First Total Synthesis of Solomonsterol B, a Marine Pregnane X Receptor Agonist
Valentina Sepe et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2012)
A Highly Selective and Specific PET Tracer for Imaging of Tau Pathologies
Wei Zhang et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Clinical Validation of 18F-AZD4694, an Amyloid-β-Specific PET Radioligand
Zsolt Cselenyi et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
The challenges of tau imaging
Victor L. Villemagne et al.
FUTURE NEUROLOGY (2012)
Specific estrogen sulfotransferase (SULT1E1) substrates and molecular imaging probe candidates
Graham B. Cole et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Evaluation of Tracer Kinetic Models for Analysis of [F-18]FDDNP Studies
Maqsood Yaqub et al.
MOLECULAR IMAGING AND BIOLOGY (2009)
PET radiotracers: crossing the blood-brain barrier and surviving metabolism
Victor W. Pike
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Peripheral metabolism of [18F]FDDNP and cerebral uptake of its labelled metabolites
Gert Luurtsema et al.
NUCLEAR MEDICINE AND BIOLOGY (2008)
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2006)
Human sulfotransferases and their role in chemical metabolism
N Gamage et al.
TOXICOLOGICAL SCIENCES (2006)
Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B
JC Price et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Species-dependent formation and identification of the brain metabolites of the amyloid imaging agent [11C]PIB
CA Mathis et al.
NEUROBIOLOGY OF AGING (2004)
Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment
AL Guillozet et al.
ARCHIVES OF NEUROLOGY (2003)
Share Paper
